What is the official website of Johnson & Johnson Innovative Medicine ?

The official website of Johnson & Johnson Innovative Medicine is https://innovativemedicine.jnj.com/.

What is Johnson & Johnson Innovative Medicine's cybersecurity risk score?

Johnson & Johnson Innovative Medicine has an AI-generated cybersecurity risk score of 807 out of 1000, indicating a Good security posture according to Rankiteo's assessment.

How many security incidents has Johnson & Johnson Innovative Medicine experienced?

According to Rankiteo, Johnson & Johnson Innovative Medicine currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Johnson & Johnson Innovative Medicine been affected by any supply chain cyber incidents ?

According to Rankiteo, Johnson & Johnson Innovative Medicine has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Johnson & Johnson Innovative Medicine have SOC 2 Type 1 certification ?

According to Rankiteo, Johnson & Johnson Innovative Medicine is not certified under SOC 2 Type 1.

Does Johnson & Johnson Innovative Medicine have SOC 2 Type 2 certification ?

According to Rankiteo, Johnson & Johnson Innovative Medicine does not hold a SOC 2 Type 2 certification.

Does Johnson & Johnson Innovative Medicine comply with GDPR ?

According to Rankiteo, Johnson & Johnson Innovative Medicine is not listed as GDPR compliant.

Does Johnson & Johnson Innovative Medicine have PCI DSS certification ?

According to Rankiteo, Johnson & Johnson Innovative Medicine does not currently maintain PCI DSS compliance.

Does Johnson & Johnson Innovative Medicine comply with HIPAA ?

According to Rankiteo, Johnson & Johnson Innovative Medicine is not compliant with HIPAA regulations.

Does Johnson & Johnson Innovative Medicine have ISO 27001 certification ?

According to Rankiteo,Johnson & Johnson Innovative Medicine is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Johnson & Johnson Innovative Medicine operate in ?

Johnson & Johnson Innovative Medicine operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Johnson & Johnson Innovative Medicine have ?

Johnson & Johnson Innovative Medicine employs approximately 37,729 people worldwide.

Does Johnson & Johnson Innovative Medicine own any subsidiaries ?

Johnson & Johnson Innovative Medicine presently has no subsidiaries across any sectors.

How many LinkedIn followers does Johnson & Johnson Innovative Medicine have ?

Johnson & Johnson Innovative Medicine's official LinkedIn profile has approximately 1,383,959 followers.

What is the NAICS classification code for Johnson & Johnson Innovative Medicine ?

Johnson & Johnson Innovative Medicine is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Johnson & Johnson Innovative Medicine have a Crunchbase profile ?

Yes, Johnson & Johnson Innovative Medicine has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/janssen.

Does Johnson & Johnson Innovative Medicine have a LinkedIn profile ?

Yes, Johnson & Johnson Innovative Medicine maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/jnjinnovativemedicine.

How many cybersecurity incidents has Johnson & Johnson Innovative Medicine experienced ?

As of July 15, 2026, Rankiteo reports that Johnson & Johnson Innovative Medicine has not experienced any cybersecurity incidents.

How many peer or competitor companies does Johnson & Johnson Innovative Medicine have ?

Johnson & Johnson Innovative Medicine has an estimated 5,708 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

JJIM

Boost Score +25 with badge (5 left)

807

/1000

Good

832

/1000

Good

Johnson & Johnson Innovative Medicine Vendor Cyber Rating & Cyber Score

jnj.com

cb in

Add Your Compliance Badge

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

JJIM A.I CyberSecurity Scoring

Scoring History

JJIM

Johnson & Johnson Innovative Medicine CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

JJIM Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for JJIM

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.

Incident Types JJIM vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.

Incident History - JJIM (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Johnson & Johnson Innovative Medicine Subsidiaries

JJIM

Pharmaceutical Manufacturing

Website: https://innovativemedicine.jnj.com/

Company Size: 10,001+ employees

J&J Innovative Medicine BelgiumPharmaceutical Manufacturing

J&J Innovative Medicine NederlandGeneesmiddelenproductie

J&J Medical Affairs OncologyPharmaceutical Manufacturing

Johnson & Johnson Innovative Medicine, CanadaPharmaceutical Manufacturing

SPRAVATO® (esketamine) for HCPsPharmaceutical Manufacturing

Loading…

Johnson & Johnson Innovative Medicine Similar Companies

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Loading…

NEWS

Johnson & Johnson Innovative Medicine CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 12, 2026 11:02 PM

Veteran safety C.J. Gardner-Johnson signs with Bills

Free agent safety C. J. Gardner-Johnson is signing a one-year deal worth up to $6 million with the Buffalo Bills, agents Kevin Conner and...

Read Article

March 12, 2026 11:00 PM

Bears News: Chicago Loses DB to Buffalo Bills

According to ESPN's Adam Schefter, Chicago Bears free-agent safety CJ Gardner-Johnson has signed a one-year deal with the Buffalo Bills.

Read Article

March 12, 2026 10:56 PM

Trump's SAVE Act push creates new FISA problem for Mike Johnson

Reauthorizing Section 702 of FISA is shaping up to be a major headache for House Speaker Mike Johnson.

Read Article

March 12, 2026 10:55 PM

Johnson's 25 help Akron defeat Buffalo 73-70 in Mid-American Conference Tournament

Led by Tavari Johnson's 25 points, the Akron Zips defeated the Buffalo Bulls 73-70 in the Mid-American Conference Tournament on Thursday.

Read Article

March 12, 2026 10:54 PM

Former Bears defensive back CJ Gardner-Johnson signs with Bills

Gardner-Johnson appeared in 10 regular season games for Chicago, with two interceptions and 35 tackles...

Read Article

March 12, 2026 10:53 PM

Ex-Eagles DB, Super Bowl champion signing elsewhere in free agency

The Philadelphia Eagles won't be bringing back safety C.J. Gardner-Johnson, who is signing with the Buffalo Bills.

Read Article

March 12, 2026 10:52 PM

Bills sign former Eagles safety C.J. Gardner-Johnson to one-year deal

Former Eagles free-agent safety C.J. Gardner-Johnson signed a one-year deal worth up to $6 million with the Bills after finishing the 2025...

Read Article

March 12, 2026 10:50 PM

Wisconsin senators react to Iran conflict: Baldwin seeks hearings, Johnson backs President Trump

As the conflict with Iran continues, Wisconsin U.S. Senators Ron Johnson and Tammy Baldwin are speaking out.

Read Article

March 12, 2026 10:50 PM

Wisconsin senators react to Iran conflict: Baldwin seeks hearings, Johnson supports Trump

As the conflict with Iran continues, Wisconsin U.S. Senators Ron Johnson and Tammy Baldwin are speaking out.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-58489

SUMMARY

HedgeDoc is an open source, real-time collaborative markdown notes application. Prior to 1.11.0, the GitHub Gist export flow created an OAuth2 state value but only checked that it was present rather than validating it against the value expected for the user's session. Because the state was not properly validated, an attacker could forge a callback URL containing their own valid GitHub OAuth code. When processing the callback, HedgeDoc used the victim's logged-in session to select which note to export, but the attacker's authorization code to determine which GitHub account received it. As a result, a logged-in victim who clicked a crafted link could export their own private, protected, or limited note directly into a Gist controlled by the attacker. This issue has been fixed in version 1.11.0.

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: )

cvss4

Base Score: 6.8

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:A/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-58486

SUMMARY

HedgeDoc is an open source, real-time, collaborative, markdown notes application. Prior to version 1.11.0, HedgeDoc was vulnerable to a YAML alias bomb due to unsafe processing of the note frontmatter. HedgeDoc parsed frontmatter with js-yaml.load (js-yaml v3) via @hedgedoc/meta-marked, which resolved YAML anchor aliases. A compact malicious payload could therefore expand into a huge object structure, consuming excessive CPU. This expansion ran on every request to the publish view (/s/<shortid>) and, when placed under the opengraph key, the editor view (/<noteId>). A ten-level alias bomb could block the single Node.js event loop for roughly 235 seconds per request, causing concurrent requests to hang or drop and rendering the instance unavailable (DoS). Because the note was stored in the database, the impact survived process restarts until the note was removed. toobusy-js did not reliably mitigate the worst cases, as the event loop was saturated before the middleware could respond. This issue was fixed in version 1.11.0.

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: )

cvss4

Base Score: 8.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-58102

SUMMARY

Crypt::OpenSSL::X509 versions before 2.1.3 for Perl allow a heap out-of-bounds read via a long certificate extension OID in hv_exts. When building the extension hash (via extensions(), extensions_by_long_name(), extensions_by_oid(), or has_extension_oid()), the code passes OBJ_obj2txt()'s return value as the hash-key length; because that value is the OID's full text length rather than the bytes written to the fixed-size buffer (129 bytes), an OID whose text is longer than the 129-byte buffer causes a read past the allocation, exposing adjacent heap memory as the returned hash key. extensions_by_name() uses the static shortname path and is not affected.

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-58101

SUMMARY

Crypt::OpenSSL::X509 versions before 2.1.3 for Perl allow denial of service via NULL pointer dereference. X509V3_EXT_d2i(ext) returns NULL when an extension's DER value fails to parse. basicC, ia5string, and auth_att dereference its result without a NULL check. keyid_data also dereferences akid->keyid, which is NULL for an empty AKI SEQUENCE (DER 30 00) even when the parse succeeds. A caller invoking an affected helper on an extension from an untrusted certificate triggers a SIGSEGV that crashes the Perl process.

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-57856

SUMMARY

Cockpit CMS contains a path traversal vulnerability in the Bucket file storage API (/system/buckets/api). The api() method in modules/System/Controller/Buckets.php sanitizes the bucket name with preg_replace('/[^a-zA-Z0-9-_\\.]/','', $bucket), which permits '..' and '../' sequences. The sanitized value is interpolated into a Flysystem path as uploads://buckets/{bucket}. Flysystem's WhitespacePathNormalizer resolves 'buckets/..' to the empty string (the uploads storage root) without raising PathTraversalDetected because the '..' has a preceding component to consume. An authenticated low-privileged user can send a crafted request with a '../' bucket name to list, upload, and delete files across all buckets, including those belonging to other users or roles

Published

Date2026-07-13

Updated

Date2026-07-13

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…